Pylopass™
Product description
A postbiotic solution that may help
reduce the load of H. pylori in the stomach
Sold in 40+ countries, patented, documented effect 10+ clinical trials.
Category leading in China. Award winner FIC 2022 in the following categories:
•Annual Highest Attention Postbiotics
•Annual Most Influential B2B company
•Annual Most Innovative Strain
Read more
Sold in 40+ countries, patented, documented effect 10+ clinical trials.
Category leading in China. Award winner FIC 2022 in the following categories:
•Annual Highest Attention Postbiotics
•Annual Most Influential B2B company
•Annual Most Innovative Strain
Specifications
Categories | Postbiotics |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
Product Applications | Dietary Supplements |
Product Certifications | Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Quality assurance; Sustainable Seafood; Vegan; Vegetarian |
Pylopass™